Comparaison de deux outils de mesure des effets indésirables d’un traitement antidépresseur : la notification spontanée et l’échelle UKU
Authors:
- C. GuryCGC. Gury
- M.-F. PoirierMPM.-F. Poirier
- O. BouvetOBO. Bouvet
- A. GérardAGA. Gérard
- M.-C. BourdelMBM.-C. Bourdel
- F.-J. BayléFBF.-J. Baylé
- J.-P. OliéJOJ.-P. Olié
- 1 October 2004
- journal article
- research article
- Published by Elsevier in L'Encéphale
- Vol. 30 (5) , 425-432
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Completeness of Safety Reporting in Randomized TrialsJAMA, 2001
- Third-Generation AntidepressantsCNS Drugs, 2001
- Evaluating the Tolerability of the Newer AntidepressantsJournal of Nervous & Mental Disease, 1999
- A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatientsInternational Clinical Psychopharmacology, 1998
- A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practiceInternational Clinical Psychopharmacology, 1997
- Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patientsJournal of Sex & Marital Therapy, 1997
- Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatientsInternational Clinical Psychopharmacology, 1996
- Controlled comparison of milnacipran and fluoxetine in major depressionPsychopharmacology, 1994
- Subjective Complaints During Desipramine TreatmentArchives of General Psychiatry, 1984
- CLINICAL OBSERVATIONS IN MANIC-DEPRESSIVE DISEASEJAMA, 1957